Catalent
CTLT
$55.48
Share price
-0.57%
Change (1 day)
31.84%
Change (1 year)
Categories
Catalent is an American pharmaceutical contract research and development company.
EPS for Catalent (CTLT)
EPS in 2023 (TTM): -$1.29
According to Catalent's latest financial reports the company's current EPS (TTM) is -$1.29. In 2022 the company made an earnings per share (EPS) of $2.27 a decrease over its 2021 EPS that were of $3.27.
EPS history for Catalent from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$1.29 | -156.83% |
| 2022 | $2.27 | -30.58% |
| 2021 | $3.27 | 79.67% |
| 2020 | $1.82 | 114.12% |
| 2019 | $0.85 | -15% |
| 2018 | $1.00 | 75.44% |
| 2017 | $0.57 | -22.97% |
| 2016 | $0.74 | -59.56% |
| 2015 | $1.83 | 282.05% |
| 2014 | $0.48 | -378.2% |
| 2013 | -$0.17 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Supernus Pharmaceuticals
SUPN | $0.79 | -161.24% | 🇺🇸 USA |
 Jazz Pharmaceuticals JAZZ | -$1.41 | 9.30% | 🇮🇪 Ireland |
 Aerie Pharmaceuticals AERI | -$0.75 | -41.86% | 🇺🇸 USA |
 Intercept Pharmaceuticals
ICPT | $6.39 | -595.35% | 🇺🇸 USA |